Zhang, Y., et al. CD25+ cell depletion enhances protective immunity of PR8 inactivated influenza vaccine in aged mice. Virology, 2026 Aug, 621:110938. PMID: 42107283
This paper highlights the synergistic potential of combining saponin-based ISCOM adjuvants with immune regulatory modulation, specifically transient depletion of CD25+ re...
Read More
Pyles, K., et al. Intranasal and intramuscular H5-Matrix-M nanoparticle vaccines protects against highly pathogenic H5N1 influenza virus in mice. NPJ Vaccines, 2026 Jul 10. PMID: 42431930
This study evaluates the immunogenicity and protective efficacy of a recombinant H5 hemagglutinin (HA) nanoparticle vaccine adjuvanted with Matrix-M, administered either ...
Read More
Haupt, S., et al. Rapid boosting increases germinal center responses to sequential vaccines. Nat Immunol, 2026 Jul, 27(7):1476-1489. PMID: 42337116
This paper explores how rapid boosting strategies can significantly enhance germinal center (GC) responses in the context of HIV vaccination, particularly emphasizing the...
Read More
Kilic, G., et al. Age-related differences in immune responses to inactivated influenza and adjuvanted recombinant herpes zoster vaccines. JCI Insight, 2026 Jun 2. PMID: 42228420
This paper uniquely explores how the adjuvant AS01 enhances immune responses in aged populations, focusing on its role in overcoming immunosenescence. By comparing respon...
Read More
Dagnew, A.F., et al. Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine. Vaccine, 2026 Jul 11, 85:128690. PMID: 42119392
This paper presents the design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine, which incorporates the AS01 adjuvant s...
Read More
Zarrinpanah, T., et al. Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology. Hum Vaccin Immunother, 2026 Dec, 22(1):2684345. PMID: 42405958
This paper offers a comprehensive overview of next-generation vaccine adjuvants, with particular emphasis on nanotechnology, systems immunology, and computational approac...
Read More
Bogoyavlenskiy, A., et al. Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures. Molecules, 2026 Jul 17, 31(14):2501. PMID: 42513179
This paper provides a comprehensive overview of advanced nanoparticle-based vaccine platforms, including a focused emphasis on saponin-derived self-assembling nanoplatfor...
Read More
Jansen, J., et al. Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency. PLoS One, 2026 Jul 20, 21(7):e0348959. PMID: 42475333
This paper is a significant contribution to the field of saponin-based adjuvants, particularly highlighting the potent immunostimulatory capacity of the saponin-MPLA nano...
Read More